Major bleeding · patients with symptomatic VTE requiring long term treatment (3 months) for symptomatic VTE
LMWH may leads to lower incidence of major bleeding (treatment duration 3 months) compared with VKA (low certainty).
1 finding from 1 review
Mortality (treatment duration 3 months) · patients with symptomatic VTE requiring long term treatment (3 months) for symptomatic VTE
LMWH showed no clear difference in mortality (treatment duration 3 months) compared with VKA (moderate certainty).
1 finding from 1 review
Intervention not reported
Heparin‐induced thrombocytopenia (HIT) · people undergoing surgical procedures and treated with UFH or LMWH for prophylaxis of thrombotic events lasting at least 5 days
The intervention may leads to lower heparin‐induced thrombocytopenia (HIT) (low certainty).
1 finding from 1 review
Intervention not reported
HIT in people undergoing major surgical procedures · people undergoing surgical procedures and treated with UFH or LMWH for prophylaxis of thrombotic events lasting at least 5 days
The intervention may leads to lower HIT in people undergoing major surgical procedures (low certainty).
1 finding from 1 review
Intervention not reported
HIT complicated by venous thromboembolism · people undergoing surgical procedures and treated with UFH or LMWH for prophylaxis of thrombotic events lasting at least 5 days
The intervention may leads to lower HIT complicated by venous thromboembolism (low certainty).
1 finding from 1 review
Clinical improvement: Rutherford classification improvement Rutherford classification · 95 people with Rutherford 3 to 5 TASC‐II D lesions
Subintimal angioplasty with stenting showed no clear difference in clinical improvement: Rutherford classification improvement… compared with remote endarterectomy (low certainty).
1 finding from 1 review
Technical success · 52 people with TASC‐II D superficial femoral artery chronic total occlusions
OUTBACK re‐entry catheter showed no clear difference in technical success rate compared with manual re‐entry (low certainty).
1 finding from 1 review
months' patency rate · 52 people with TASC‐II D superficial femoral artery chronic total occlusions
OUTBACK re‐entry catheter showed no clear difference in months' patency rate compared with manual re‐entry (low certainty).
2 findings from 1 review
Primary patency ( · 52 people with TASC‐II D superficial femoral artery chronic total occlusions
2 findings from 1 review
Limb salvage · 52 people with TASC‐II D superficial femoral artery chronic total occlusions
1 finding from 1 review
Complications · 52 people with TASC‐II D superficial femoral artery chronic total occlusions
1 finding from 1 review
Clinical improvement: ABI improvement Significant postexercise ABI improvement · 95 people with Rutherford 3 to 5 TASC‐II D lesions
Subintimal angioplasty with stenting showed no clear difference in clinical improvement: ABI improvement Significant postexercise ABI… compared with remote endarterectomy (low certainty).
1 finding from 1 review
Technical success · 95 people with Rutherford 3 to 5 TASC‐II D lesions
Subintimal angioplasty with stenting showed no clear difference in technical success rate compared with remote endarterectomy (low certainty).
1 finding from 1 review
months' patency rate · 95 people with Rutherford 3 to 5 TASC‐II D lesions
Subintimal angioplasty with stenting showed no clear difference in months' patency rate compared with remote endarterectomy (low certainty).
3 findings from 1 review
RR 0.75 [0.57, 1]
1 study · 95 participants
Low
RR 0.74 [0.55, 1]
1 study · 95 participants
Low
RR 0.76 [0.52, 1.11]
1 study · 95 participants
Low
Limb salvage · 95 people with Rutherford 3 to 5 TASC‐II D lesions
Subintimal angioplasty with stenting showed no clear difference in months' limb salvage rate compared with remote endarterectomy (low certainty).
1 finding from 1 review
Complications · 95 people with Rutherford 3 to 5 TASC‐II D lesions
Subintimal angioplasty with stenting showed no clear difference in complications compared with remote endarterectomy (low certainty).
1 finding from 1 review
Clinical improvement · 52 people with TASC‐II D superficial femoral artery chronic total occlusions
1 finding from 1 review